AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35125067 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load exercise with blood-flow restriction (LL-BFR)
Number of subjects: 17
Study 35125067 — intervention group
Group type: COMPARATOR
Intervention: Low-load free-flow (LL-FF)
Number of subjects: 17
Study 36186488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting the risk of readmission in patients with HFrEF
Number of subjects: 0
Study 32076468 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Support Ventilation (ASV)
Number of subjects: 24
Study 32076468 — intervention group
Group type: COMPARATOR
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 24
Study 34916384 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (Arm A): 55 Gy in 20 fractions at 2.75 Gy per fraction, 5 days a week.
Number of subjects: 50
Study 34916384 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (Arm B): 66 Gy in 33 fractions at 2 Gy per fraction, 5 days a week.
Number of subjects: 50
Study 34916384 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (Arm A)
Number of subjects: 50
Study 34916384 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (Arm B)
Number of subjects: 50
Study 32155018 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical combination therapy with 5% imiquimod cream, 2% 5-FU solution, and 0.1% tretinoin cream, applied five nights per week under occlusion for a treatment goal of 30 total applications.
Number of subjects: 1
Study 32469406 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART initiation within 14 days from admission
Number of subjects: 82
Study 32469406 — intervention group
Group type: COMPARATOR
Intervention: Delayed ART initiation until nutritional recovery and >14 days after admission
Number of subjects: 82
Study 33355918 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton beam therapy
Number of subjects: 0
Study 33355918 — intervention group
Group type: COMPARATOR
Intervention: Standard radiotherapy
Number of subjects: 0
Study 32576275 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential behavior therapeutic smoking cessation therapy
Number of subjects: 0
Study 32576275 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient behavior therapeutic smoking cessation group therapy
Number of subjects: 0
Study 35154550 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone group (spinal anesthesia with 0.5% ropivacaine and 75 μg hydromorphone)
Number of subjects: 80
Study 35154550 — intervention group
Group type: COMPARATOR
Intervention: Morphine group (spinal anesthesia with 0.5% ropivacaine and 150 μg morphine)
Number of subjects: 80
Study 35154550 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone group
Number of subjects: 80
Study 35154550 — intervention group
Group type: COMPARATOR
Intervention: Morphine group
Number of subjects: 80
Study 35154550 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 33596734 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS) applied to the injured (ACL) motor cortex leg representation (M1LEG)
Number of subjects: 20
Study 33596734 — intervention group
Group type: COMPARATOR
Intervention: sham iTBS
Number of subjects: 20
Study 33582693 — intervention group
Group type: COMPARATOR
Intervention: Standard Triple Drug Therapy
Number of subjects: 62
Study 33582693 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential Drug Therapy
Number of subjects: 62
Study 37737025 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintilimab regimen
Number of subjects: 0
Study 37737025 — intervention group
Group type: COMPARATOR
Intervention: Observational management
Number of subjects: 0
Study 34420177 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffolds (BRS)
Number of subjects: 103
Study 34420177 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting metallic stents (EES)
Number of subjects: 103
Study 34420177 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffolds (BRS) in STEMI patients
Number of subjects: 103
Study 34420177 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting metallic stents (EES) in STEMI patients
Number of subjects: 103
Study 35108620 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief hypnotic induction with reduced preoperative local anesthetics (Dave Elman technique)
Number of subjects: 33
Study 35108620 — intervention group
Group type: COMPARATOR
Intervention: Regular preoperative local anesthetics without brief hypnotic induction (standard care)
Number of subjects: 33
Study 35108620 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief hypnotic induction
Number of subjects: 33
Study 35108620 — intervention group
Group type: COMPARATOR
Intervention: Standard care (regular local anesthetics)
Number of subjects: 33
Study 34358827 — intervention group
Group type: COMPARATOR
Intervention: Leucine supplementation
Number of subjects: 200
Study 34358827 — intervention group
Group type: COMPARATOR
Intervention: Whey supplementation
Number of subjects: 200
Study 34358827 — intervention group
Group type: COMPARATOR
Intervention: Soy supplementation
Number of subjects: 200
Study 34358827 — intervention group
Group type: COMPARATOR
Intervention: Creatine supplementation
Number of subjects: 200
Study 34358827 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 200
Study 34358827 — intervention group
Group type: COMPARATOR
Intervention: Whey supplementation (sex-based response)
Number of subjects: 200
Study 35088725 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acustimulation (TEA)
Number of subjects: 50
Study 34346662 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 0
Study 34346662 — intervention group
Group type: COMPARATOR
Intervention: Model-based approach
Number of subjects: 0
Study 34346662 — intervention group
Group type: COMPARATOR
Intervention: Epidemiological or real-life 'big data'
Number of subjects: 0
Study 32573449 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D imaging classification system
Number of subjects: 50
Study 35839109 — intervention group
Group type: EXPERIMENTAL
Intervention: EBN intervention
Number of subjects: 72
Study 35839109 — intervention group
Group type: COMPARATOR
Intervention: Conventional perioperative care
Number of subjects: 72
Study 33052555 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide 120 mg every 28 days
Number of subjects: 89
Study 33052555 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for patients with progressive disease at the end of the core study)
Number of subjects: 89
Study 32584211 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 200
Study 32584211 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic-Focused Psychodynamic Psychotherapy (PFPP)
Number of subjects: 200
Study 32584211 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Relaxation Training (ART)
Number of subjects: 200
Study 35348615 — intervention group
Group type: EXPERIMENTAL
Intervention: Nickel-titanium closed-coil springs (CS)
Number of subjects: 48
Study 35348615 — intervention group
Group type: COMPARATOR
Intervention: Elastomeric power chains (PC)
Number of subjects: 48
Study 34644368 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low carbohydrate diet (VLCBD) (<20g daily intake)
Number of subjects: 30
Study 34644368 — intervention group
Group type: COMPARATOR
Intervention: Standard low protein diet (LPD) (0.8g/kg/day)
Number of subjects: 30
Study 32586077 — intervention group
Group type: COMPARATOR
Intervention: SQ‐PAP
Number of subjects: 17
Study 32586077 — intervention group
Group type: COMPARATOR
Intervention: HT‐PAP
Number of subjects: 17
Study 36038516 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifunctional laser photoelectric platform combined with hydroxychloroquine (0.2 g, twice a day)
Number of subjects: 226
Study 36038516 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine sulfate tablets (0.2 g, twice a day)
Number of subjects: 226
Study 32092140 — intervention group
Group type: EXPERIMENTAL
Intervention: Andexanet alfa
Number of subjects: 0
Study 35429850 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral GNB with 0.125% bupivacaine, 0.5 xylocaine, and 4 mg dexamethasone
Number of subjects: 400
Study 35429850 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2)
Number of subjects: 400
Study 34256820 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased maternal speech exposure (treatment group, n = 21)
Number of subjects: 42
Study 34256820 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care (control group, n = 21)
Number of subjects: 42
Study 32543161 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (2 ml, 0.25 mg/ml suspension for nebulizer) administered within 6 hours of birth and a second dose 12 hours later.
Number of subjects: 100
Study 32543161 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalation (2 ml of distilled sterile water).
Number of subjects: 100
Study 35232482 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary integrative care (IC)
Number of subjects: 201
Study 35232482 — intervention group
Group type: COMPARATOR
Intervention: Chiropractic care (CC)
Number of subjects: 201
Study 34699407 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% sucrose
Number of subjects: 85
Study 34699407 — intervention group
Group type: COMPARATOR
Intervention: Water (placebo)
Number of subjects: 85
Study 34194390 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided curettage with UAE
Number of subjects: 200
Study 34194390 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guided curettage without UAE
Number of subjects: 200
Study 33567942 — intervention group
Group type: EXPERIMENTAL
Intervention: Handshake Protocol (warm handoff approach)
Number of subjects: 0
Study 33567942 — intervention group
Group type: COMPARATOR
Intervention: Standard enrollment process (not explicitly detailed)
Number of subjects: 0
Study 34518568 — intervention group
Group type: EXPERIMENTAL
Intervention: AI group (n=15) - performed 3 squat sets: 10 unassisted control squats, 10 squats with performance feedback from AI, and 10 additional unassisted test squats.
Number of subjects: 30
Study 34518568 — intervention group
Group type: EXPERIMENTAL
Intervention: PT group (n=15) - performed 3 identical sets, receiving performance feedback from PT.
Number of subjects: 30
Study 35705944 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 61
Study 35705944 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 61
Study 32595203 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood culture
Number of subjects: 12000
Study 32595203 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine culture
Number of subjects: 12000
Study 36198026 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline circulating tumor cells (CTCs) ≥ 5
Number of subjects: 103
Study 36198026 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher CTC counts
Number of subjects: 103
Study 34818400 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + L-PRF
Number of subjects: 34
Study 34818400 — intervention group
Group type: COMPARATOR
Intervention: CAF + CTG
Number of subjects: 34
Study 32790671 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (posters, lectures, distant electronic learning, reminders)
Number of subjects: 3
Study 32790671 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 3
Study 32790671 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study 35206331 — intervention group
Group type: EXPERIMENTAL
Intervention: mhGAP training delivered by mental health specialists
Number of subjects: 205
Study 35206331 — intervention group
Group type: COMPARATOR
Intervention: RESHAPE training delivered by specialists and people with lived experience of mental illness
Number of subjects: 205
Study 34565424 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral episiotomy during vacuum-assisted delivery
Number of subjects: 23
Study 34565424 — intervention group
Group type: COMPARATOR
Intervention: No episiotomy during vacuum-assisted delivery
Number of subjects: 23
Study 36943681 — intervention group
Group type: EXPERIMENTAL
Intervention: EMME (eye movement modeling examples) group; 5-min ultrasound examination videos with expert's eye movements.
Number of subjects: 106
Study 36943681 — intervention group
Group type: COMPARATOR
Intervention: Control group; identical videos without eye movements.
Number of subjects: 106
Study 32943239 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted an extra daily cup of tea consumption
Number of subjects: 349376
Study 32669215 — intervention group
Group type: EXPERIMENTAL
Intervention: Puppet show during circumcision
Number of subjects: 81
Study 32669215 — intervention group
Group type: COMPARATOR
Intervention: Control group (no puppet show)
Number of subjects: 81
Study 34921756 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg/day for 35 days
Number of subjects: 320
Study 34921756 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 320
Study 32024551 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior quadratus lumborum block (QLB) using 0.25% levobupivacaine
Number of subjects: 0
Study 32024551 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 0
Study 32024551 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior quadratus lumborum block (QLB)
Number of subjects: 0
Study 35443696 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-measured physical activity (PA)
Number of subjects: 106
Study 35443696 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal physical activity
Number of subjects: 106
Study 35443696 — intervention group
Group type: COMPARATOR
Intervention: Child PA
Number of subjects: 106
Study 33499679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex calculated using corrected body weight (CBW), 4 mg/kg
Number of subjects: 125
Study 33499679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex calculated using total body weight (TBW), 4 mg/kg
Number of subjects: 125
Study 33499679 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 125
Study 33112758 — intervention group
Group type: EXPERIMENTAL
Intervention: Web conference systems for IRB meetings; 21 facilities implemented these systems.
Number of subjects: 31
Study 35587284 — intervention group
Group type: EXPERIMENTAL
Intervention: semirigid extension-locked knee bracing for 8 days post-operatively
Number of subjects: 72
Study 35587284 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bracing)
Number of subjects: 72
Study 34193056 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg/daily
Number of subjects: 0
Study 34193056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35166163 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive face
Number of subjects: 38
Study 35166163 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative face
Number of subjects: 38
Study 35166163 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral face
Number of subjects: 38
Study 35166163 — intervention group
Group type: COMPARATOR
Intervention: Control (white screen)
Number of subjects: 38
Study 33633195 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 32
Study 33633195 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 32
Study 32108022 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors and statins (oral drugs)
Number of subjects: 443
Study 36011510 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (50% VO2max)
Number of subjects: 79
Study 36011510 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (80% VO2max)
Number of subjects: 79
Study 36011510 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Moderate and High-intensity)
Number of subjects: 79
Study 33562247 — intervention group
Group type: EXPERIMENTAL
Intervention: Bench-step exercise training (BSET)
Number of subjects: 28
Study 33562247 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 28
Study 32485622 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 78
Study 32485622 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 36013137 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle Touch Therapy (GTT)
Number of subjects: 64
Study 36013137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 35259147 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (synchronized radiofrequency and HIFEM)
Number of subjects: 72
Study 35259147 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 72
Study 33687872 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous left atrial appendage occlusion (LAAO) using Watchman, ACP, and Amulet devices
Number of subjects: 0
Study 33687872 — intervention group
Group type: COMPARATOR
Intervention: Long-term oral anticoagulation (OAC) with direct oral anticoagulants (DOACs)
Number of subjects: 0
Study 32004567 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast + NB-UVB
Number of subjects: 80
Study 32004567 — intervention group
Group type: COMPARATOR
Intervention: Placebo + NB-UVB
Number of subjects: 80
Study 36419103 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort Young Child Formula (test group)
Number of subjects: 95
Study 36419103 — intervention group
Group type: COMPARATOR
Intervention: Comfort Young Child Formula (control group)
Number of subjects: 95
Study 33599431 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (1000 mg daily for 8 weeks)
Number of subjects: 54
Study 33599431 — intervention group
Group type: COMPARATOR
Intervention: Medium chain triglyceride (1000 mg daily for 8 weeks)
Number of subjects: 54
Study 34866304 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC/3TC/DTG
Number of subjects: 91
Study 34866304 — intervention group
Group type: COMPARATOR
Intervention: TDF/FTC/NNRTI
Number of subjects: 91
Study 33818429 — intervention group
Group type: EXPERIMENTAL
Intervention: Torsion group III (min 240)
Number of subjects: 28
Study 33818429 — intervention group
Group type: EXPERIMENTAL
Intervention: Torsion groups (I, II, III)
Number of subjects: 28
Study 33818429 — intervention group
Group type: COMPARATOR
Intervention: Control group IV (min 240)
Number of subjects: 28
Study 33726523 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS)
Number of subjects: 69
Study 33726523 — intervention group
Group type: COMPARATOR
Intervention: continuous theta burst stimulation (cTBS)
Number of subjects: 69
Study 33218559 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping combined with the motor relearning method (12 sessions)
Number of subjects: 10
Study 33218559 — intervention group
Group type: COMPARATOR
Intervention: Motor relearning method (12 sessions)
Number of subjects: 10
Study 36135352 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc-hydroxyapatite-based paste applied on 2 MIH teeth in one random quadrant (test group)
Number of subjects: 25
Study 36135352 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 contralateral MIH teeth without paste application)
Number of subjects: 25
Study 34053154 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolisation (UAE)
Number of subjects: 254
Study 34053154 — intervention group
Group type: COMPARATOR
Intervention: Myomectomy
Number of subjects: 254
Study 32073408 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted CPR (V-CPR)
Number of subjects: 150
Study 32073408 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-assisted CPR (T-CPR)
Number of subjects: 150
Study 32073408 — intervention group
Group type: COMPARATOR
Intervention: Unassisted CPR (Control)
Number of subjects: 150
Study 35489044 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT‐ILE training (90 hours over 2 weeks)
Number of subjects: 31
Study 35489044 — intervention group
Group type: COMPARATOR
Intervention: Control group (customary treatment)
Number of subjects: 31
Study 33581370 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Support Index (assessed through support from mother, mother-in-law, husband, relatives)
Number of subjects: 240
Study 33581370 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner Support Index (assessed through husband's support)
Number of subjects: 240
Study 33581370 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Shift Index (shift of attention from mother to baby)
Number of subjects: 240
Study 34758069 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib (420 mg daily)
Number of subjects: 363
Study 34758069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363
Study 34503367 — intervention group
Group type: EXPERIMENTAL
Intervention: IM20-4 (20μg, 4 doses)
Number of subjects: 303
Study 34503367 — intervention group
Group type: EXPERIMENTAL
Intervention: IM60-4 (60μg, 4 doses)
Number of subjects: 303
Study 34503367 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term high-strength vaccination group (4 doses)
Number of subjects: 303
Study 34503367 — intervention group
Group type: COMPARATOR
Intervention: Standard vaccination group (3 doses)
Number of subjects: 303
Study 36216035 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand‐hold technique
Number of subjects: 316
Study 36216035 — intervention group
Group type: COMPARATOR
Intervention: Lanyard technique
Number of subjects: 316
Study 36216035 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand‐hold technique and Lanyard technique
Number of subjects: 316
Study 33451954 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (1 mg/kg as a bolus before aortic cross‐clamping and 2 mg/kg mixed in the cardioplegia solution)
Number of subjects: 200
Study 33451954 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 200
Study 616082720 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal fluid aspiration
Number of subjects: 20
Study 616082720 — intervention group
Group type: COMPARATOR
Intervention: Inverted ILM flap technique
Number of subjects: 20
Study 36206005 — intervention group
Group type: EXPERIMENTAL
Intervention: ETC group (financial incentives for home dialysis use)
Number of subjects: 18621